July 5, 2022

Écoute naturelle : Lancement de la toute nouvelle barre de son Hisense U5120G en Afrique du Sud

LE CAP, Afrique du Sud, 5 juillet 2022 /PRNewswire/ — Hisense, fabricant de produits électroniques de renommée mondiale, a récemment annoncé le lancement de la dernière génération de sa barre de son U5120G en Afrique du Sud. Disponible à partir du 29 juin chez Takealot, Tafelberg, HiFi Corp et Hirsch, la barre de son U5120G, puissante et facile à utiliser, sera commercialisée au prix de 7 999 rands sud-africains et devrait être un élément populaire des systèmes de divertissement à domicile, offrant aux consommateurs une expérience digne des salles de cinéma.

La barre de son innovante U5120G est dotée de 11 haut-parleurs multidirectionnels intégrés et d’un caisson de basse sans fil de 180 watts, pour un total de 510 watts de son de haute qualité. Le caisson de basse de huit pouces peut reproduire des sons de tout juste 40 Hz, ce qui permet d’ajouter des effets de basse profonds et puissants aux films, aux émissions de télévision, aux jeux et à la musique. Les appareils sont faciles à connecter et sont compatibles avec la technologie Bluetooth, pour une configuration en toute simplicité.

En ce qui concerne l’expérience sonore, la disposition des enceintes à l’intérieur de la barre de son U5120G crée un système surround avec un véritable son 5.1.2 ch. Un utilisateur a fait remarquer que, contrairement aux systèmes de son surround classiques, qui ne permettent d’obtenir les meilleurs effets surround qu’à un spectateur, la barre de son U5120G, grâce à sa fonction intuitive DTS Virtual:X et Dolby Atmos, fournit un son surround immersif et chaleureux à 360 degrés, peut importe l’emplacement des utilisateurs dans la pièce.

La barre de son U5120G prend en charge les sons haute résolution, ce qui lui confère une qualité sonore comparable à celle des studios d’enregistrement et des salles de concert. Sa technologie Hi-Remaster lui permet d’améliorer la qualité sonore d’autres sources d’entrée telles que les CD et les MP3. De nombreux utilisateurs ont salué cette fonction, affirmant qu’elle amplifiait les sons compressés en un signal audio plus étendu, plus chaud et plus riche qui ajoute de la profondeur et de la dimension à la musique ou aux films. Pour les besoins audio haut de gamme tels que les films et les jeux, la barre de son U5120G prend également en charge la 4k et la 3D, en traitant les données sans perte de qualité et en améliorant considérablement l’expérience globale de divertissement.

D’après les commentaires des utilisateurs, la barre de son U5120G peut être fixée facilement à un mur. Elle est également simple à configurer, grâce à une télécommande unique qui prend en charge EzPlay et à des menus intuitifs pour la personnalisation et le passage d’un mode audio à un autre. Si les utilisateurs ne souhaitent pas changer de mode audio manuellement, le mode AI EQ assisté par la technologie Hi-AT assure l’optimisation du son pour chaque scène. Que vous regardiez du sport, un film ou les actualités, que vous écoutiez de la musique ou que vous jouiez à un jeu, le mode AI EQ peut détecter votre activité et s’adapter afin de vous offrir la meilleure expérience sonore possible.

Photo – https://mma.prnewswire.com/media/1852729/U520G.jpg

July 5, 2022

Cellebrite and Chainalysis Partner to Modernize Digital Investigations by Unlocking Cryptocurrency Data

Two market leaders come together to expand digital investigations

PETAH TIKVA, Israel and TYSONS CORNER, Va. and NEW YORK, July 05, 2022 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, and Chainalysis, the blockchain data platform, have launched a partnership to enable customers to easily identify and assess criminal activity involving cryptocurrency during digital investigations to expedite their resolution.

Cryptocurrency usage has increased significantly over the past several years. While the vast majority of its use is for legitimate purposes, it has also been exploited for illicit use in scamming, money laundering, ransomware, and more. As cryptocurrency artifacts are more frequently found in, and can be used as key pieces of, digital evidence, law enforcement and corporations need access to cryptocurrency-related knowledge and tools to investigate criminal activity and help solve cases.

Together, Cellebrite and Chainalysis are enabling customers to modernize investigations by leveraging the transparency of blockchains. The integrated solution will provide automated, efficient capabilities and knowledge to identify and assess cryptocurrency risks and correlate such information to additional elements of a related case. Cellebrite’s DI suite of solutions will reveal accurate, real-time cryptocurrency data and insights from Chainalysis’ data platform. As a result of this cooperation, examiners, investigators, analysts, and compliance officers will be able to seamlessly identify illicit cryptocurrency-related activity in a single place as part of their familiar digital investigation workflows.

Cellebrite and Chainalysis are also collaborating to empower customers to bridge the cryptocurrency knowledge gap. Together, they will educate customers’ internal experts by offering cryptocurrency training and delivering cryptocurrency expert investigation services, as well as making Chainalysis’ Reactor, the investigation tool, available for advanced cryptocurrency tracing.

“Cryptocurrency, as any other financial instrument, has become a vehicle for funding crime and laundering money, and as its adoption increases, our customers must be equipped with cutting-edge solutions to identify this important category of digital evidence,” said Leeor Ben-Peretz, Chief Strategy Officer at Cellebrite. “Providing our customers with an integrated cryptocurrency investigation solution will expedite their investigations through automation and help them seamlessly uncover a wider range of digital evidence within Cellebrite’s suite of Digital Intelligence solutions. We are happy to join forces with Chainalysis to further enhance our customers’ tools and knowledge, modernize investigations, and accelerate justice.”

“We are thrilled to partner with Cellebrite, the Digital Intelligence market leader, to expand our public and private sector customer reach and provide them access to Chainalysis’ solutions, training, and expertise,” said Thomas Stanley, President and Chief Revenue Officer at Chainalysis. “Together, Cellebrite and Chainalysis are committed to helping combat blockchain-related crime, improving trust and transparency in blockchains, and making cryptocurrency safer for all.”

The initial integrated solution is expected to be available in Q3 2022. To find out more about the partnership offerings, please visit: https://cellebrite.com/en/cellebrite-crypto-solution-powered-by-chainalysis/

About Cellebrite

Cellebrite’s (NASDAQ: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com, https://investors.cellebrite.com, or follow us on Twitter at @Cellebrite.

About Chainalysis

Chainalysis is the blockchain data platform. We provide data, software, services, and research to government agencies, exchanges, financial institutions, and insurance and cybersecurity companies in over 70 countries. Our data powers investigation, compliance, and market intelligence software that has been used to solve some of the world’s most high-profile criminal cases and grow consumer access to cryptocurrency safely. Backed by Accel, Addition, Benchmark, Coatue, GIC, Paradigm, Ribbit, and other leading firms in venture capital, Chainalysis builds trust in blockchains to promote more financial freedom with less risk. For more information, visit www.chainalysis.com.

Caution Regarding Forward Looking Statements
This document includes “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “will,” “appear,” “approximate,” “foresee,” “might,” “possible,” “potential,” “believe,” “could,” “predict,” “should,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include estimated financial information. Such forward-looking statements with respect to revenues, earnings, performance, strategies, prospects, and other aspects of Cellebrite’s business are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite’s ability to keep pace with technological advances and evolving industry standards; Cellebrite’s material dependence on the acceptance of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite’s DI solutions; Cellebrite’s failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; uncertainties regarding the impact of macroeconomic and/or global conditions, including COVID-19 and military actions involving Russia and Ukraine; intense competition in all of Cellebrite’s markets; the inadvertent or deliberate misuse of Cellebrite’s solutions; political and reputational factors related to Cellebrite’s business or operations; risks relating to estimates of market opportunity and forecasts of market growth; Cellebrite’s ability to properly manage its growth; risks associated with Cellebrite’s credit facilities and liquidity; Cellebrite’s reliance on third-party suppliers for certain components, products, or services; challenges associated with large transactions and long sales cycle; risks that Cellebrite’s customers may fail to honor contractual or payment obligations; risks associated with a significant amount of Cellebrite’s business coming from government customers around the world; risks related to Cellebrite’s intellectual property; security vulnerabilities or defects, including cyber-attacks, information technology system breaches, failures or disruptions; the mishandling or perceived mishandling of sensitive or confidential information; the complex and changing regulatory environments relating to Cellebrite’s operations and solutions; the regulatory constraints to which we are subject; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite’s shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite’s significant international operations; risks associated with Cellebrite’s failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite’s existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite’s current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled “Risk Factors” in Cellebrite’s annual report on form 20-F filed with the SEC on March 29, 2022 and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission (“SEC”), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Cellebrite Media
Victor Cooper
Public Relations and Corporate Communications Director
+1 404.804.5910
Victor.cooper@cellebrite.com

Cellebrite Investors
Anat Earon-Heilborn
VP Investor Relations
+972 73 394 8440
investors@cellebrite.com

Chainalysis Media
Maddie Kennedy
Senior Director of Communications
media@chainalysis.com
Contact Chainaylsis

July 5, 2022

Angola debut with victory in Cosafa Cup

Luanda – The Angolan national football team beat the Comoros islands by 3-1 in the group A game of the Cosafa Cup, at the Zwelithini stadium in Durban, South Africa.

The goals were scored by Megue, at 38 minutes, Lépua (47`) and Ezequiel Higino (75`).

For the Comoros islands, Alin Nassim scored at 76`.

Developing news story.

Source: Angola Press News Agency

July 5, 2022

USAID announces up to $46 million for Malawi private sector engagement initiative “Let Them Grow Healthy”

The U.S. government, through the U.S. Agency for International Development (USAID), announced the launch of Let Them Grow Healthy (Tiwalere) in Malawi today. Tiwalere is a five-year, $46 million initiative, subject to appropriations, in support of the Government of Malawi’s National Multi-Sector Nutrition Policy. It is anticipated that USAID will invest $23 million and that the private sector will match this by also contributing $23 million.

This alliance of for-profit corporations, non-governmental organizations, and USAID aims to improve the health of Malawians, particularly adolescents, pregnant and lactating women, and children by expanding quality nutrition, maternal and child health, water and sanitation, and malaria program coverage. A focus of the project will be pregnancy through a child’s second birthday, when good nutrition and health care are critical for growth and development. The initiative will support local care groups and communities to produce a local, nutritious fortified food product that would be distributed through a sustainable, market-based approach.

Malawi has achieved dramatic gains in most health indicators over the past decade by focusing on improved delivery of essential health services. With support from the U.S. government, Malawi has made significant progress in child health, reducing mortality for children under age five by 50 percent and malaria-related mortality by 43 percent since 2010. USAID partners with the Government of Malawi to continue addressing these challenges.

Source: US Agency of International Development

July 5, 2022

Chinese City of 13 Million Shuts Down Again to Avoid COVID ‘Explosion’

Businesses, schools and restaurants in Xi’an will close for one week, officials said Tuesday, after the Chinese city logged a handful of COVID-19 cases as outbreaks nationwide strain Beijing’s zero-tolerance virus approach.

China is the last major economy wedded to a zero-COVID strategy, deploying snap lockdowns, quarantines and travel curbs in a bid to weed out new infections.

Xi’an — a historic city of 13 million that endured a month-long lockdown at the end of last year — has reported 18 cases since Saturday in a cluster driven by the fast-spreading Omicron variant, according to official notices.

City official Zhang Xuedong said at a Tuesday press conference that Xi’an would implement “seven-day temporary control measures” that would “allow society to quieten down as much as possible, reduce mobility… and cut the risk of cross-infection”.

“We must race against both time and the virus… to guard against all possible risks and hidden dangers, and decisively avoid an explosion in community spreading,” Zhang said.

Public entertainment venues including pubs, internet cafes and karaoke bars would shut their doors from midnight on Wednesday, the city government said in a notice.

Restaurants will not be allowed to serve diners indoors but may continue to offer takeaway services, it said.

Schools are to start the summer holiday early and universities will seal off their campuses.

Xi’an — home to the Terracotta Warriors — previously experienced one of China’s longest stay-at-home orders, shutting off for a month between December and January as thousands of COVID cases were detected.

City authorities came under fire for their handling of the lockdown, which was plagued by food supply issues and medical tragedies stemming from patients being denied access to hospitals.

Some residents in the tourist city expressed dismay at the closures on social media Tuesday.

“It’s like they’re addicted to lockdowns. What else do they even do?” wrote one on the Twitter-like Weibo platform.

“Here we go again,” complained another.

China logged 335 new domestic cases on Tuesday, most of which were asymptomatic, according to the National Health Commission (NHC).

China’s latest significant flare-up is in central Anhui province, where 1.7 million people in two counties were under orders to stay at home as of Tuesday.

Around 90% of the nearly 300 infections reported in the province on Monday were asymptomatic, according to the NHC. Over 1,000 cases have been detected during the outbreak so far.

Separately, city officials in Shanghai have launched a new round of mandatory COVID testing in most districts after “successively recording many local positive cases” since Sunday.

Many of the commercial hub’s 25 million people will have to take two tests between Tuesday and Thursday, authorities said.

Despite a grueling, two-month citywide lockdown being formally lifted at the end of May, parts of Shanghai have simmered under local lockdowns and testing drives after finding sporadic new cases.

Source: Voice of America

July 5, 2022

New US Study Helps Demystify Long COVID Brain Fog

A small new study published Tuesday by scientists at the U.S. National Institutes of Health suggests that the immune response triggered by coronavirus infections damages the brain’s blood vessels and could be responsible for long COVID symptoms.

The paper, published in the journal Brain, was based on brain autopsies from nine people who died suddenly after contracting the virus.

Rather than detecting evidence of COVID in the brain, the team found it was the people’s own antibodies that attacked the cells lining the brain’s blood vessels, causing inflammation and damage.

This discovery could explain why some people have lingering effects from infection including headache, fatigue, loss of taste and smell, and inability to sleep as well as “brain fog” — and may also help devise new treatments for long COVID.

NIH scientist Avindra Nath, the paper’s senior author, said in a statement: “Patients often develop neurological complications with COVID-19, but the underlying pathophysiological process is not well understood.

“We had previously shown blood vessel damage and inflammation in patients’ brains at autopsy, but we didn’t understand the cause of the damage. I think in this paper we’ve gained important insight into the cascade of events.”

The nine individuals, ages 24 to 73, were selected from the team’s earlier study because they showed evidence of blood vessel damage in their brains based on scans.

Their brains were compared to those from 10 control individuals.

The scientists discovered that antibodies produced against COVID-19 mistakenly targeted cells that form the blood-brain barrier, a structure designed to keep harmful invaders out of the brain while allowing necessary substances to pass.

Damage to these cells can cause leakage of proteins, bleeding and clots, which elevates the risk of stroke.

The leaks also trigger immune cells called macrophages to rush to the site to repair damage, causing inflammation.

The team found that normal cellular processes in the areas targeted by the attack were severely disrupted, which had implications for things such as their ability to detoxify and to regulate metabolism.

The findings offer clues about the biology at play in patients with long-term neurological symptoms, and can inform new treatments, for example, a drug that targets the buildup of antibodies on the blood-brain barrier.

“It is quite possible that this same immune response persists in long COVID patients resulting in neuronal injury,” Nath said.

This would mean that a drug that dials down that immune response could help those patients, he added. “So these findings have very important therapeutic implications.”

Source: Voice of America